IL185308A0 - Replikin peptides and uses thereof - Google Patents

Replikin peptides and uses thereof

Info

Publication number
IL185308A0
IL185308A0 IL185308A IL18530807A IL185308A0 IL 185308 A0 IL185308 A0 IL 185308A0 IL 185308 A IL185308 A IL 185308A IL 18530807 A IL18530807 A IL 18530807A IL 185308 A0 IL185308 A0 IL 185308A0
Authority
IL
Israel
Prior art keywords
replikin peptides
replikin
peptides
Prior art date
Application number
IL185308A
Original Assignee
Bogoch Samuel
Elenore S Bogoch
Samuel Winston Bogoch
Anne Elenore Borsanyi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2005/014443 external-priority patent/WO2005104754A2/en
Application filed by Bogoch Samuel, Elenore S Bogoch, Samuel Winston Bogoch, Anne Elenore Borsanyi filed Critical Bogoch Samuel
Publication of IL185308A0 publication Critical patent/IL185308A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/10—Sequence alignment; Homology search
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
IL185308A 2005-02-16 2007-08-16 Replikin peptides and uses thereof IL185308A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US65308305P 2005-02-16 2005-02-16
PCT/US2005/014443 WO2005104754A2 (en) 2004-04-28 2005-04-28 System and method for identifying complex patterns of amino acids
PCT/US2006/005343 WO2006088962A2 (en) 2005-02-16 2006-02-16 Replikin peptides and uses thereof

Publications (1)

Publication Number Publication Date
IL185308A0 true IL185308A0 (en) 2008-02-09

Family

ID=36917023

Family Applications (1)

Application Number Title Priority Date Filing Date
IL185308A IL185308A0 (en) 2005-02-16 2007-08-16 Replikin peptides and uses thereof

Country Status (8)

Country Link
EP (1) EP1859063A4 (en)
JP (1) JP2008539164A (en)
AU (1) AU2006214332B2 (en)
CA (1) CA2598381A1 (en)
IL (1) IL185308A0 (en)
NZ (1) NZ560415A (en)
SG (1) SG160327A1 (en)
WO (1) WO2006088962A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7420028B2 (en) 2001-03-27 2008-09-02 Samuel Bogoch Replikins and methods of identifying replikin-containing sequences
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
WO2008060702A2 (en) * 2006-05-30 2008-05-22 Samuel Bogoch Replikin peptides and uses thereof
US8050871B2 (en) 2006-10-24 2011-11-01 Samuel Bogoch Method of predicting influenza outbreaks by correlating an increase in replikin count in shrimp white spot syndrome virus and/or taura syndrome virus
WO2008143717A2 (en) 2007-01-18 2008-11-27 Samuel Bogoch Methods of determining lethality of pathogens and malignancies involving replikin peak genes
JP5675348B2 (en) * 2007-05-30 2015-02-25 ボゴーク，サミュエル Synthetic Replikin Peptides against Invertebrate Pathogenic Infections in Aquaculture
JP2011519837A (en) * 2008-04-23 2011-07-14 ボゴック，サミュエル Methods and compounds for mitigating pathogen outbreaks using Replikin Count Cycle
EP2320932B1 (en) * 2008-08-08 2015-07-15 Samuel Bogoch Methods of predicting cancer lethality using replikin counts
US9233148B2 (en) * 2009-01-09 2016-01-12 Samuel Bogoch Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza
AU2009344843A1 (en) * 2009-04-23 2011-11-10 Elenore S. Bogoch Replikin-sequences for preventing/treating influenza and determining infectivity/lethality
CA2842345A1 (en) 2011-07-20 2013-01-24 Samuel Bogoch Peptides shared among lethal cancers and therapeutic compositions comprising said peptides
WO2013151662A2 (en) 2012-03-09 2013-10-10 Samuel Bogoch Therapies, vaccines, and predictive methods for infectious salmon anemia virus

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0221748A3 (en) 1985-11-01 1988-10-12 Samuel Dr. Bogoch A process for the production of human antibodies
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US6242578B1 (en) 1994-02-17 2001-06-05 Samuel Bogoch Aglyco products and methods of use
US7420028B2 (en) * 2001-03-27 2008-09-02 Samuel Bogoch Replikins and methods of identifying replikin-containing sequences
US7442761B2 (en) * 2003-06-06 2008-10-28 Samuel Bogoch Replikin peptides and uses thereof
US11620305B2 (en) 2021-03-25 2023-04-04 Salesforce.Com, Inc Ruleset engine for generating homogeneous data sets

Also Published As

Publication number Publication date
AU2006214332A1 (en) 2006-08-24
WO2006088962A3 (en) 2008-01-24
WO2006088962A9 (en) 2006-11-16
WO2006088962A2 (en) 2006-08-24
AU2006214332B2 (en) 2012-03-22
SG160327A1 (en) 2010-04-29
CA2598381A1 (en) 2006-08-24
NZ560415A (en) 2010-05-28
EP1859063A2 (en) 2007-11-28
JP2008539164A (en) 2008-11-13
EP1859063A4 (en) 2012-02-01

Similar Documents

Publication Publication Date Title
IL228770A0 (en) Processes and intermaediates
EP1920216A4 (en) Location signposting and orientation
IL222922A (en) Anti-neuropilin-1 antibodies and uses thereof
EP1976864A4 (en) Novel peptide and use thereof
IL184428A0 (en) Peptides with neuropeptide-2-receptor
IL185308A0 (en) Replikin peptides and uses thereof
GB0508863D0 (en) Peptide
IL179497A0 (en) Carboranylporphyrins and uses thereof
IL195525A0 (en) Replikin peptides and uses thereof
GB0604187D0 (en) Peptide and uses thereof
IL180365A0 (en) Carboranylporphyrins and uses thereof
ZA200801874B (en) Antigenic peptides and their use
EP1953227A4 (en) Lipopolysaccharide- or lipid a-binder, and novel peptide
GB0517293D0 (en) Vectors and uses thereof
GB0526019D0 (en) Peptides
GB0516527D0 (en) Peptides
GB0516571D0 (en) Novel polypeptides and uses thereof
GB0617564D0 (en) Peptides and methods
IL192800A0 (en) Fgf2-binding peptides and uses thereof
EP1876238A4 (en) Novel polypeptide and use thereof
GB0517813D0 (en) Peptides and uses thereof
EP1910405A4 (en) Complement c3a derived peptides and uses thereof
GB0612873D0 (en) Isolated peptides and uses thereof
GB0425731D0 (en) Isolated peptides and uses thereof
GB0503093D0 (en) Ricin-binding peptide and methods for use thereof